Skip to main content
Home
  • en
  • fr
  • Profile
    • About DEINOVE
    • Board of Directors
    • Executive Committee
    • Founders
    • A word from the CEO
  • Antibiotics
    • About
    • Antimicrobial resistance
    • Portfolio
    • The AGIR program
    • Discovery platform
    • Partners
  • Bioactives
    • About
    • Biodiversity
    • Portfolio
    • Platform of Expertise
    • Partners
  • Investor room
    • Corporate governance
    • DEINOVE Shares
    • Financial Calendar
    • Documentation Center
    • Press releases
    • Investor relations
  • News & events
    • Press releases
    • Events
    • Press coverage
  • Careers
    • Join DEINOVE
    • Open positions
  1. Home
  2. Investor room
  3. Documentation Center
  4. Financial Reports

Financial Reports

Interim financial report 2019
Annual financial report 2018
Interim financial report 2018
Annual financial report 2017
Interim financial report 2017
Annual financial report 2016
Interim financial report 2016
Annual financial report 2015
Interim financial report 2015
Annual financial report 2014
Interim financial report 2014
Reference document 2013
Annual financial report 2013
Interim financial report 2013
Annual financial report 2012
Interim financial report 2012
Annual financial report 2011
Interim financial report 2011 (French version)
Annual financial report 2010 (French version)
Interim financial report 2010 (French version)

Investor room

  • Corporate governance
    • Board of Directors
    • Executive Committee
  • DEINOVE Shares
  • Financial Calendar
  • Documentation Center
    • Financial Reports
    • Investor presentations
    • Analyst Coverage
    • Newsletter to Shareholders
    • Shareholders' Meetings
    • Shares and Voting Rights
    • Transactions on company securities
    • Liquidity Agreement
    • Public offerings - Documentation
    • Obligations Convertibles en Actions (OCA)
  • Press releases
  • Investor relations
  • Contact
  • Location
  • Legal Info
  • Site map
  • Privacy Policy

Profile

  • About DEINOVE
  • Board of Directors
  • Executive Committee
  • Founders
  • A word from the CEO

Antibiotics

  • About
  • Antimicrobial resistance
  • Portfolio
  • The AGIR program
  • Discovery platform
  • Partners

Bioactives

  • About
  • Biodiversity
  • Portfolio
  • Platform of Expertise
  • Partners

Investor room

  • Corporate governance
  • DEINOVE Shares
  • Financial Calendar
  • Documentation Center
    • Financial Reports
    • Investor presentations
    • Analyst Coverage
    • Newsletter to Shareholders
    • Shareholders' Meetings
    • Shares and Voting Rights
    • Transactions on company securities
    • Liquidity Agreement
    • Public offerings - Documentation
    • Obligations Convertibles en Actions (OCA)
  • Press releases
  • Investor relations

Careers

  • Join DEINOVE
  • Open positions

News & events

  • Press releases
  • Events
  • Press coverage

Downloads

  • Investor presentations
  • Analyst Coverage
  • Financial Reports

Follow us

Stay in touch

Subscribe to our newsletter

Contact us

ZAC Euromédecine II, Cap Sigma, 1682 Rue de la Valsière, 34790 Grabels, France

+33 (0)4 48 19 01 00

Home